—

Fairmount Funds Management LLC

Q4 2025 13F Holdings

  • Location
    west conshohocken, PA
  • Num holdings

    13

  • Value ($000)

    $1,313,784

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001802528
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$319.8M
24 %

9,003,418

A
APGE

APOGEE THERAPEUTICS INC

COM
03770N101
$154.63M
12 %

2,048,647

S
SYRE

SPYRE THERAPEUTICS INC

COM NEW
00773J202
$131.63M
10 %

4,018,101

V
VRDN

VIRIDIAN THERAPEUTICS INC

COM
92790C104
$121.82M
9 %

3,914,458

---

ORUKA THERAPEUTICS INC

COM
687604108
$112.31M
9 %

3,705,262

D
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$88.07M
7 %

2,137,191

---

ZENAS BIOPHARMA INC

COM
98937L105
$80.21M
6 %

2,209,025

N
NUVL

NUVALENT INC

COM
670703107
$73.19M
6 %

727,563

---

JADE BIOSCIENCES INC

COM NEW
008064206
$70.26M
5 %

4,553,494

E
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$57.16M
4 %

3,711,444

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 13